Altered Serotonin 1B Receptor Binding After Escitalopram for Depression Is Correlated With Treatment Effect von Gärde, M, Matheson, G J, Varnäs, K, Svenningsson, P, Hedman-Lagerlöf, E, Lundberg, J, Farde, L, Tiger, M

Volltext

Associations Between Cognition and Serotonin 1B Receptor Availability in Healthy Volunteers: A [11C]AZ10419369 Positron Emission Tomography Study von Tangen, Ämma, Veldman, Emma R, Svensson, Jonas, Tiger, Mikael, Nord, Magdalena, Sorjonen, Kimmo, Andersson, Max, Plavén-Sigray, Pontus, Varrone, Andrea, Halldin, Christer, Varnäs, Katarina, Borg, Jacqueline, Lundberg, Johan

Volltext

Integrated Strategy for Use of Positron Emission Tomography in Nonhuman Primates to Confirm Multitarget Occupancy of Novel Psychotropic Drugs: An Example with AZD3676 von Varnäs, Katarina, Juréus, Anders, Johnström, Peter, Ahlgren, Charlotte, Schött, Pär, Schou, Magnus, Gruber, Susanne, Jerning, Eva, Malmborg, Jonas, Halldin, Christer, Afzelius, Lovisa, Farde, Lars

Volltext

P.1.g.069 Relationship between dose, plasma concentration and GABA-A receptor occupancy by partial GABA-A receptor modulators von Jucaite, A, Lappalainen, J, Cselenyi, Z, Varnäs, K, Stenkrona, P, Halldin, C, Cross, A, Farde, L

Volltext

Autoradiographic distribution of serotonin transporters and receptor subtypes in human brain von Varnäs, Katarina, Halldin, Christer, Hall, Håkan

Volltext

Mapping the distribution of serotonin transporter in the human brainstem with high-resolution PET: Validation using postmortem autoradiography data von Fazio, P., Schain, M., Varnäs, K., Halldin, C., Farde, L., Varrone, A.

Volltext

145. Translocator protein (TSPO) as a biomarker of microglia activation: PET imaging using [11C]PBR28 in Parkinson’s disease von Jucaite, A, Cselényi, Z, Varrone, A, Varnäs, K, Johnström, P, Halldin, C, Salter, H, McLoughlin, M.J, Rinne, J, Svenningsson, P, Alexander, R, Kugler, A, Farde, L

Volltext

Amphetamine decreases binding of the novel alpha2C-adrenoreceptor radioligand [11C]ORM-13070 in monkey brain von Finnema, S.J., Varnäs, K., Stepanov, V., Varrone, A., Gulyás, B., Arponen, E., Helin, S., Solin, O., Haaparanta, M., Sallinen, J., Ingman, K., Scheinin, M., Farde, L., Halldin, C.

Volltext

11 Early clinical development of amyloid-beta specific PET radioligand [18F]AZD4694 von Cselényi, Zsolt, Forsberg, A, Halldin, C, Schou, M, Johnström, P, Varnäs, K, Svensson, S, Andreasen, N, Reiman, E.M, Eriksdotter-Jönhagen, M, Farde, L

Volltext

Associations between cognition and serotonin receptor 1B binding in patients with major depressive disorder – a pilot study von Tangen, Ämma, Borg, Jacqueline, Tiger, Mikael, Varnäs, Katarina, Sorjonen, Kimmo, Lindefors, Nils, Halldin, Christer, Lundberg, Johan

Volltext

The 5-HT1B receptor - a potential target for antidepressant treatment von Tiger, Mikael, Varnäs, Katarina, Okubo, Yoshiro, Lundberg, Johan

Volltext

The 5-HT 1B receptor - a potential target for antidepressant treatment von Tiger, Mikael, Varnäs, Katarina, Okubo, Yoshiro, Lundberg, Johan

Volltext

Synthesis and biological evaluation of technetium(III) mixed-ligand complexes with high affinity for the cerebral 5-HT1A receptor and the alpha1-adrenergic receptor von DREWS, A, PIETZSCH, H.-J, SPIES, H, JOHANNSEN, B, SYHRE, R, SEIFERT, S, VARNÄS, K, HALL, H, HALLDIN, C, KRAUS, W, KARLSSON, P, JOHNSSON, C

Volltext

Discovery and Evaluation of Clinical Candidate AZD3759, a Potent, Oral Active, Central Nervous System-Penetrant, Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor von Zeng, Qingbei, Wang, Jiabing, Cheng, Ziqiang, Chen, Kan, Johnström, Peter, Varnäs, Katarina, Li, David Yunzhi, Yang, Zhen Fan, Zhang, Xiaolin

Volltext

Preclinical Comparison of Osimertinib with Other EGFR-TKIs in EGFR-Mutant NSCLC Brain Metastases Models, and Early Evidence of Clinical Brain Metastases Activity von Ballard, Peter, Yates, James W T, Yang, Zhenfan, Kim, Dong-Wan, Yang, James Chih-Hsin, Cantarini, Mireille, Pickup, Kathryn, Jordan, Angela, Hickey, Mike, Grist, Matthew, Box, Matthew, Johnström, Peter, Varnäs, Katarina, Malmquist, Jonas, Thress, Kenneth S, Jänne, Pasi A, Cross, Darren

Volltext

Autoradiographic mapping of synaptic vesicle glycoprotein 2A in non‐human primate and human brain von Varnäs, Katarina, Stepanov, Vladimir, Halldin, Christer

Volltext

Effect of the myeloperoxidase inhibitor AZD3241 on microglia: a PET study in Parkinson's disease von Jucaite, Aurelija, Svenningsson, Per, Rinne, Juha O, Cselényi, Zsolt, Varnäs, Katarina, Johnström, Peter, Amini, Nahid, Kirjavainen, Anna, Helin, Semi, Minkwitz, Margaret, Kugler, Alan R, Posener, Joel A, Budd, Samantha, Halldin, Christer, Varrone, Andrea, Farde, Lars

Volltext

PET Evaluation of the Novel F‑18 Labeled Reversible Radioligand [18F]GEH200449 for Detection of Monoamine Oxidase‑B in the Non-Human Primate Brain von Varnäs, Katarina, Nag, Sangram, Halldin, Christer, Farde, Lars

Volltext

Preclinical Comparison of the Blood-brain barrier Permeability of Osimertinib with Other EGFR TKIs von Colclough, Nicola, Chen, Kan, Johnström, Peter, Strittmatter, Nicole, Yan, Yumei, Wrigley, Gail L, Schou, Magnus, Goodwin, Richard, Varnäs, Katarina, Adua, Sally J, Zhao, Minghui, Nguyen, Don X, Maglennon, Gareth, Barton, Peter, Atkinson, James, Zhang, Lin, Janefeldt, Annika, Wilson, Joanne, Smith, Aaron, Takano, Akihiro, Arakawa, Ryosuke, Kondrashov, Mikhail, Malmquist, Jonas, Revunov, Evgeny, Vazquez-Romero, Ana, Moein, Mohammad Mahdi, Windhorst, Albert D, Karp, Natasha A, Finlay, M Raymond V, Ward, Richard A, Yates, James W T, Smith, Paul D, Farde, Lars, Cheng, Zack, Cross, Darren A E

Volltext

PET imaging of [11C]PBR28 in Parkinson’s disease patients does not indicate increased binding to TSPO despite reduced dopamine transporter binding von Varnäs, Katarina, Cselényi, Zsolt, Jucaite, Aurelija, Halldin, Christer, Svenningsson, Per, Farde, Lars, Varrone, Andrea

Volltext